Skip to main content

Grundlagen der Therapiedurchführung

  • Chapter
  • 1919 Accesses

Zusammenfassung

Die Ziele bei der Therapie der tiefen Beinvenenthrombose (TVT) lassen sich differenzieren in Sofort- bzw. Akutziele und Spät- bzw. Fernziele:

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   49.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zu 9.1

  • Breddin HK (2005) Tiefe Beinvenenthrombose: Pathogenese, Diagnostik und Therapie. Phlebologie 34:5–14

    Google Scholar 

  • Diehm C, Stammler F, Amendt K (1997) Tiefe Venenthrombose. Diagnostik und Therapie. Dt Ärztebl 94:235–245

    Google Scholar 

  • Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ for the American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel (2012) Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9thed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:7S–47S

    Google Scholar 

  • Hach-Wunderle V, Blättler W, Gerlach H, Konstantinides St, Noppeney T, Pillny M, Riess H, Schellong S, Stiegler H, Wildberger JE (2010) Diagnostik und Therapie der Venenthrombose und der Lungenembolie.Interdisziplinäre S2 Leitlinie. VASA (Suppl): S78/2010

    Google Scholar 

  • Hull RD, Pineo GF (1999) Medical treatment of acute deep vein thrombosis and pulmonary embolism. In: Gloviczki P, et al. (eds) Handbook of venous disorders, 3rd ed. Hodder Arnold, London

    Google Scholar 

  • Kearon C, Akl EA, Comerota AJ et al. (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guide lines. Chest 141 (Suppl): e419S-e494S

    Google Scholar 

Zu 9.2

  • Ageno W, Agnelli, Imberti, Moia M, Palareti G, Pistelli R, Rossi R, Verso M for the MASTER Investigators (2008) Factors associated with the timing of diagnosis of venous thromboembolism: Results from the MASTER registry. Thromb Res 121:751–756

    Google Scholar 

  • Elliott CG, Goldhaber SZ, Jensen RL (2005) Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest 128:3372–3376

    Google Scholar 

  • Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ for the American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel (2012) Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9thed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:7S–47S

    Google Scholar 

  • Hach-Wunderle V, Blättler W, Gerlach H, Konstantinides St, Noppeney T, Pillny M, Riess H, Schellong S, Stiegler H, Wildberger JE (2010) Diagnostik und Therapie der Venenthrombose und der Lungenembolie. Interdisziplinäre S2 Leitlinie. VASA (Suppl): S78/2010

    Google Scholar 

  • Mostbeck A, Partsch H, Köhn H, König B (1980) Lungenembolie bei Bein- Beckenvenenthrombose: Ergebnisse einer prospektiven Studie. Diagnostik, Häufigkeit, nuklearmedizinisches und klinisches Erscheinungsbild. Wien Klin Wochenschr 92:464–471

    Google Scholar 

Zu 9.3

  • Nüllen H, Noppeney T (2010) Kompressionstherapie. In: Noppeney N (Hrsg) Varikose. Springer, Heidelberg, S 230ff

    Google Scholar 

  • Nüllen H, Noppeney T (2011) Kompressionstherapie - Theoretische Grundlagen. Phlebologie 40:3–8

    Google Scholar 

  • Partsch H, Rabe E, Stemmer R (1999) Kompressionstherapie der Extremitäten. Editions Phlebologiques Francaises, Paris

    Google Scholar 

  • Weidinger P (1989) Kompressionsstrumpf - Hilfe oder Trauma - Patientenstatistik. In: Denk, van Dongen (Hrsg) Therapie der Venenerkrankungen. TM Verlag, Hameln, S 131–134

    Google Scholar 

Zu 9.4

  • Kahn SR, Shrier I, Julian, JA, Ducruet T, Arsenault L, Miron MJ, Roussin R, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS (2008) MDDeterminants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis. Ann Intern Med 149:698–707

    Google Scholar 

Zu 9.5

  • Dempfle CE (2012) Pharmakologie der neuen oralen Antikoagulantien. Herz 37:362–369

    Google Scholar 

  • Douketis JD (2012) Contra: »Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery«. Thromb Haemostas 108:210–212

    Google Scholar 

  • Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R (2012) Perioperative Management of Antithrombotic therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Chest 141, (2 Suppl): e326S–350S

    Google Scholar 

  • ESC-AF-Guidelines, www.escardio.org/guidelines-surveys/escguidelines/GuidelinesDocuments/guidelines-afib-FT.pdf

  • Fachinformation Dabigatran (Pradaxa®) FI 010964-D851-Pradaxa. Boehringer Ingelheim

    Google Scholar 

  • Fachinformation R(Xarelto®): FI 013452-E779 Xarelto. Bayer Pharma AG

    Google Scholar 

  • Jaffer AK (2009) Perioperative management of warfarin and antiplatelet therapy. Cleveland Clin J Med 76(Suppl 4):S37–S544

    Google Scholar 

  • Ortel TL (2012) Perioperative management of patients on chronic antithrombotic therapy. Blood 120:4699–4705

    Google Scholar 

  • Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey. Chest 138:1093–1100

    Google Scholar 

  • Siguret V, Pautas E, Février M, Wipff C, Durand-Gasselin B, Laurent M, Andreux JP, d´Urso M, Gaussem P (2000) Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days. Thromb Haemost 84:800–804

    Google Scholar 

  • Siguret V, Gouin-Thibault I, Pautas E, Leizorovicz A (2011) No accumulation of the peak anti-.Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy. J Thromb Haemost 9:1966–1972

    Google Scholar 

  • Spyropoulos AC (2012) Pro: »Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery«. Thromb Haemost 108:213–216

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nüllen, H., Noppeney, T., Kamphausen, U. (2014). Grundlagen der Therapiedurchführung. In: Nüllen, H., Noppeney, T., Diehm, C. (eds) VTE - Venöse Thromboembolien. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21496-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21496-7_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21495-0

  • Online ISBN: 978-3-642-21496-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics